News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
News Conference News ESC 2024 NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD Michael O'Riordan September 01, 2024
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Conference News AHA 2022 Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World Michael O'Riordan November 10, 2022
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Conference News SCAI 2016 Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women L.A. McKeown May 11, 2016